miR-34a suppresses tumorshphere formation, CSCs’ self-renewal ability, the expression of stem markers, and drug resistance in the MCF-7 breast cancer cell line by inhibiting serine/threonine-protein kinase D1 (PRKD1). This evidence concerns the gene PRKD1 and breast carcinoma.